|
Jan 21
|
Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer
|
|
Jan 20
|
Is GSK plc (GSK) an Undervalued Defensive Stock for 2025?
|
|
Jan 18
|
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
|
|
Jan 17
|
Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations
|
|
Jan 16
|
Is GSK plc (GSK) One of the Cheapest Stocks with Biggest Upside Potential?
|
|
Jan 4
|
GSK’s Nucala Gains Approval in China for CRSwNP
|
|
Jan 3
|
GSK's Sinus Disease Drug Secures Approval In China
|
|
Dec 30
|
Can GSK plc (LON:GSK) Maintain Its Strong Returns?
|
|
Oct 15
|
GSK sues Moderna for US patent infringement over COVID, RSV vaccines
|
|
Oct 14
|
GSK Says Depemokimab For Chronic Rhinosinusitis Reduces Nasal Polyp Size, Nasal Obstruction Versus Placebo At One Year
|
|
Oct 11
|
Jim Cramer Says GSK plc (GSK) ‘Goes Higher’
|
|
Oct 10
|
GSK Shares Climb on $2.2 Billion Zantac Lawsuit Settlement
|
|
Oct 10
|
Trending tickers: Tata Investment Corporation, Tesla, HSBC, GSK and BMW
|
|
Oct 10
|
FTSE 100 Live 10 October: GSK shares rise on $2.2bn Zantac settlement, property firm gets £1.1bn bid
|
|
Oct 10
|
GSK shares jump after landmark £1.68bn heartburn drug settlement
|
|
Oct 10
|
GSK Rises After Settling Zantac Cases for Up to $2.2 Billion
|
|
Oct 10
|
GSK shares jump on $2.2 billion Zantac settlement
|
|
Oct 9
|
Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday
|
|
Oct 9
|
GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits
|
|
Oct 9
|
GSK Resolves Majority Of US Zantac Cases With $2.2B Settlement Deal, Stock Surges
|